Literature DB >> 9605257

Accuracy of seven different tests for the diagnosis of Helicobacter pylori infection and the impact of H2-receptor antagonists on test results.

F Lerang1, B Moum, P Mowinckel, J B Haug, E Ragnhildstveit, T Berge, A Bjørneklett.   

Abstract

BACKGROUND: In this study we compared the accuracy of seven diagnostic tests in diagnosing Helicobacter pylori infection.
METHODS: Over 1 year 351 consecutive dyspeptic patients were tested for H. pylori infection by means of antral biopsy specimens for the rapid urease test (RUT), culture, microscopy (acridine stain), and the laboratory urease test (LUT) and, in addition, with 14C urea breath test (UBT), IgG serology, and IgA serology (Orion Diagnostica Pyloriset New EIA-G and New EIA-A). The criterion for H. pylori infection was a minimum of three positive tests. Before being tested, 38% of the patients had used an H2-receptor antagonist (H2RA).
RESULTS: Two-hundred and twenty-four patients (64%) were H. pylori-positive. The sensitivity and specificity of the tests were as follows (percentages): RUT, 85, 99; culture, 93, 100; microscopy, 81, 98; LUT, 80, 100; UBT, 95, 95; IgG serology, 99, 91; and IgA serology, 88, 91. The accuracy of the RUT and LUT was reduced in patients receiving H2RA therapy (P=0.04 and 0.01, respectively).
CONCLUSIONS: Culture, UBT, and IgG serology were all superior to the other four tests in diagnosing H. pylori infection. Invasive urease-based tests were less accurate in patients receiving H2RAs.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9605257     DOI: 10.1080/00365529850170982

Source DB:  PubMed          Journal:  Scand J Gastroenterol        ISSN: 0036-5521            Impact factor:   2.423


  15 in total

1.  Age-dependent accuracy of Helicobacter pylori antibody assays for adults, with special emphasis on atrophic gastritis.

Authors:  A Salomaa-Räsänen; T U Kosunen; J Mattila; S Sarna; H Rautelin
Journal:  Clin Diagn Lab Immunol       Date:  2004-11

Review 2.  Diagnosis of Helicobacter pylori: what should be the gold standard?

Authors:  Saurabh Kumar Patel; Chandra Bhan Pratap; Ashok Kumar Jain; Anil Kumar Gulati; Gopal Nath
Journal:  World J Gastroenterol       Date:  2014-09-28       Impact factor: 5.742

3.  Patterns of gastritis in patients with gastro-oesophageal reflux disease.

Authors:  D J Bowrey; G W Clark; G T Williams
Journal:  Gut       Date:  1999-12       Impact factor: 23.059

4.  Reliability of Helicobacter pylori and CagA serological assays.

Authors:  James E Everhart; Deanna Kruszon-Moran; Guillermo Perez-Perez
Journal:  Clin Diagn Lab Immunol       Date:  2002-03

5.  Use of tobacco products and gastrointestinal morbidity: an endoscopic population-based study (the Kalixanda study).

Authors:  Pertti Aro; Jukka Ronkainen; Tom Storskrubb; Michael Vieth; Lars Engstrand; Sven-Erik Johansson; Elisabeth Bolling-Sternevald; Gunilla Bolinder; Kjell Alving; Nicholas J Talley; Lars Agréus
Journal:  Eur J Epidemiol       Date:  2010-07-29       Impact factor: 8.082

Review 6.  Helicobacter pylori in intensive care: why we should be interested.

Authors:  Megan S Robertson; Robert L Clancy; John F Cade
Journal:  Intensive Care Med       Date:  2003-08-28       Impact factor: 17.440

Review 7.  Omeprazole. A review of its use in Helicobacter pylori infection, gastro-oesophageal reflux disease and peptic ulcers induced by nonsteroidal anti-inflammatory drugs.

Authors:  H D Langtry; M I Wilde
Journal:  Drugs       Date:  1998-09       Impact factor: 9.546

Review 8.  Diagnosis of Helicobacter pylori infection: Current options and developments.

Authors:  Yao-Kuang Wang; Fu-Chen Kuo; Chung-Jung Liu; Meng-Chieh Wu; Hsiang-Yao Shih; Sophie S W Wang; Jeng-Yih Wu; Chao-Hung Kuo; Yao-Kang Huang; Deng-Chyang Wu
Journal:  World J Gastroenterol       Date:  2015-10-28       Impact factor: 5.742

9.  Reliability of Diagnostic Tests for Helicobacter pylori Infection.

Authors:  S Redéen; F Petersson; E Törnkrantz; H Levander; E Mårdh; K Borch
Journal:  Gastroenterol Res Pract       Date:  2011-08-01       Impact factor: 2.260

10.  Assessment of Helicobacter pylori eradication in patients on NSAID treatment.

Authors:  Harald E Vonkeman; Htji Deleest; Mafj van Delaar; J Vanbaarlen; Kss Steen; Wf Lems; Jwj Bijlsma; Ej Kuipers; Hhml Houben; M Janssen; Bac Dijkmans
Journal:  BMC Gastroenterol       Date:  2012-09-24       Impact factor: 3.067

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.